Risk of Cytomegalovirus Infection after 3 or 6 Months of Valganciclovir Prophylaxis among Donor-Seropositive, Recipient-Seronegative Heart Transplant Recipients
After heart transplant, CMV D+/R- patients who received 3 months of prophylaxis had a higher risk of CMV infection and a non-statistically significant higher risk of CMV disease relative to those who received 6 months of prophylaxis.
Authors
- Nathalie Châteauvert
- Vincent Leclerc (ORCID: https://orcid.org/0000-0003-0586-1072)
Institutions
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
Publication Details
- Journal
- The Canadian Journal of Hospital Pharmacy
- Published
- 2025-05-14
- DOI
- https://doi.org/10.4212/cjhp.3701
- Citations
- 1
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.35